Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats (Q28572349)

31 January 2017

title

Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats (English)

1 reference

31 January 2017

1 reference

Bu-Chin Yu

1

1 reference

31 January 2017

Chen-Kuei Chang

2

1 reference

31 January 2017

Horng-Yih Ou

3

1 reference

31 January 2017

Kai-Chun Cheng

4

1 reference

31 January 2017

Juei-Tang Cheng

5

1 reference

31 January 2017

language of work or name

1 reference

1 October 2008

1 reference

31 January 2017

published in

Cardiovascular Research

1 reference

31 January 2017

volume

80

1 reference

31 January 2017

issue

1

1 reference

31 January 2017

page(s)

78–87

1 reference

31 January 2017

cites work

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Diabetic cardiomyopathy: the search for a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Oxidative stress and stress signaling: menace of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Oxidative stress and diabetic cardiomyopathy: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

MitoKATP channel activation suppresses gap junction permeability in the ischemic myocardium by an ERK-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Metabolic disturbances in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Insulin status differentially affects energy transduction in cardiac mitochondria from male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Exogenous attenuation of p21(Waf1/Cip1) decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172

Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN172